J. Banchereau and A. Palucka, Dendritic cells as therapeutic vaccines against cancer, Nature Reviews Immunology, vol.10, issue.4, pp.296-306, 2005.
DOI : 10.1007/s00262-003-0429-0

J. Banchereau, F. Briere, and C. Caux, Immunobiology of Dendritic Cells, Annual Review of Immunology, vol.18, issue.1, pp.767-811, 2000.
DOI : 10.1146/annurev.immunol.18.1.767

C. Watts, CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULES, Annual Review of Immunology, vol.15, issue.1, pp.821-50, 1997.
DOI : 10.1146/annurev.immunol.15.1.821

G. Moron, G. Dadaglio, and C. Leclerc, New tools for antigen delivery to the MHC class I pathway, Trends in Immunology, vol.25, issue.2, pp.92-99, 2004.
DOI : 10.1016/j.it.2003.11.008

M. Amacker, O. Engler, and A. Kammer, Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells, International Immunology, vol.17, issue.6, pp.695-704, 2005.
DOI : 10.1093/intimm/dxh249

R. Schumacher, M. Amacker, and D. Neuhaus, Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan- A/MART-1(26-35) peptide encapsulated into virosomes in vitro, Vaccine 2005. 7. Smith AE, Helenius A. How viruses enter animal cells, pp.237-279, 2004.

A. Arkema, A. Huckriede, P. Schoen, J. Wilschut, and T. Daemen, Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes, Vaccine, vol.18, issue.14, pp.1327-1360, 2000.
DOI : 10.1016/S0264-410X(99)00404-1

I. Hunziker, B. Grabscheid, R. Zurbriggen, R. Gluck, W. Pichler et al., In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus, International Immunology, vol.14, issue.6, pp.615-641, 2002.
DOI : 10.1093/intimm/dxf026

A. Amoscato, D. Prenovitz, and M. Lotze, Rapid extracellular degradation of synthetic class I peptides by human dendritic cells, J Immunol, vol.161, issue.8, pp.4023-4055, 1998.

M. Adamina, M. Bolli, and F. Albo, Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes The nature of the principal type 1 interferonproducing cells in human blood Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon, Br J Cancer Science Nat Med Colonna M Nat Immunol, vol.9028455, issue.1512, pp.263-91835, 1999.

J. Fonteneau, M. Gilliet, and M. Larsson, Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity, Blood, vol.101, issue.9, pp.3520-3526, 2003.
DOI : 10.1182/blood-2002-10-3063

L. Chaperot, A. Blum, and O. Manches, Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells, The Journal of Immunology, vol.176, issue.1, pp.248-55, 2006.
DOI : 10.4049/jimmunol.176.1.248
URL : https://hal.archives-ouvertes.fr/inserm-00286442

L. Chaperot, N. Bendriss, and O. Manches, Identification of a leukemic counterpart of the plasmacytoid dendritic cells, Blood, vol.97, issue.10, pp.3210-3217, 2001.
DOI : 10.1182/blood.V97.10.3210

N. Kadowaki, S. Ho, and S. Antonenko, Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens, The Journal of Experimental Medicine, vol.161, issue.6, pp.863-872, 2001.
DOI : 10.4049/jimmunol.166.1.249

D. Jarrossay, G. Napolitani, M. Colonna, F. Sallusto, and A. Lanzavecchia, Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells, European Journal of Immunology, vol.6, issue.11, pp.3388-93, 2001.
DOI : 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q

R. Gluck and I. Metcalfe, New technology platforms in the development of vaccines for the future, Vaccine, vol.20, pp.10-16, 2002.
DOI : 10.1016/S0264-410X(02)00513-3

S. Esposito, P. Marchisio, and S. Bosis, Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years Dendritic cells respond to influenza virus through TLR7-and PKR-independent pathways Virosome-mediated delivery of protein antigens to dendritic cells, Vaccine Eur J Immunol Vaccine, vol.243520, issue.25, pp.629-35236, 2002.

J. Mestas, C. Hughes, M. Urosevic, R. Dummer, and C. Conrad, Of mice and not men: differences between mouse and human immunology Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment, J Immunol J Natl Cancer Inst, vol.17297, issue.2715, pp.2731-81143, 2004.

D. Speiser, D. Lienard, and N. Rufer, Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909, Journal of Clinical Investigation, vol.115, issue.3, pp.739-785, 2005.
DOI : 10.1172/JCI23373

J. Blanchet, D. Valmori, and I. Dufau, A New Generation of Melan-A/MART-1 Peptides That Fulfill Both Increased Immunogenicity and High Resistance to Biodegradation: Implication for Molecular Anti-Melanoma Immunotherapy, The Journal of Immunology, vol.167, issue.10, pp.5852-61, 2001.
DOI : 10.4049/jimmunol.167.10.5852

T. Stegmann, H. Morselt, F. Booy, J. Van-breemen, G. Scherphof et al., Functional reconstitution of influenza virus envelopes, Embo J, vol.6, issue.9, pp.2651-2660, 1987.